MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Thursday, June 23, 2016

12:00pm-1:30pm
Beyond 30 years of Parkinson’s disease: A comprehensive characterization of long-surviving patients

A. Romagnolo, M.G. Rizzone, F. Dematteis, M. Zibetti, A. Merola, L. Rizzi, E. Montanaro, C.A. Artusi, M. Lanotte, L. Lopiano (Turin, Italy)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Biochemical features of lipids spectrum in blood in patients with Parkinson’s disease

Z.A. Akbarkhodjaeva, F. Saidvaliev (Tashkent, Uzbekistan)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Biseptol a new antiParkinsonian agent?

K. Karpinska, V. Smolanka (Uzhgorod, Ukraine)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Blindfolded balance training in patients with Parkinson’s disease: A sensory-motor strategy to improve the gait

A. Peppe, S. Bonnì, M. Fabio, K. Giacomo, A. Martino Cinnera, M. Tramontano, C. Caltagirone (Rome, Italy)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Body position during sleep in patients with Parkinson’s disease (PD): A sensor-based analysis

J. Sringean, P. Taechalertpaisarn, C. Thanawattano, R. Bhidayasiri (Nonthaburi, Thailand)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Botulinum neurotoxin type A versus anticholinergics for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update

F.B. Rodrigues, G.S. Duarte, R.E. Marques, M. Castelão, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Botulinum neurotoxin type A versus placebo for hemifacial spasm in adults – 2016 Cochrane movement disorders group systematic review update

M. Castelão, F.B. Rodrigues, R.E. Marques, G.S. Duarte, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Botulinum neurotoxins type A versus B for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update

M. Castelão, G.S. Duarte, F.B. Rodrigues, R.E. Marques, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Botulinum toxin A injections changes sensorimotor network activations in cervical dystonia to state more related to physiological condition

M. Nevrly, P. Hlustik, P. Otruba, P. Hok, Z. Tudos, P. Kanovsky (Olomouc, Czech Republic)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Botulinum toxin in cerebral palsy children with gait disorder: Different therapy approaches

G.S. Pilina (Izhevsk, Russia)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 53
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley